Search by Drug Name or NDC
NDC 10702-0001-25 LOMAIRA 8 mg/1 Details
LOMAIRA 8 mg/1
LOMAIRA is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by KVK-TECH, INC.. The primary component is PHENTERMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phentermine is used for a limited period of time to speed weight loss in overweight people who are exercising and eating a low-calorie diet. Phentermine is in a class of medications called anorectics. It works by decreasing appetite.
Related Packages: 10702-0001-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Phentermine
Product Information
| NDC | 10702-0001 |
|---|---|
| Product ID | 10702-001_0ce01306-ef7f-563f-e063-6394a90a52b7 |
| Associated GPIs | 61200070100305 |
| GCN Sequence Number | 005160 |
| GCN Sequence Number Description | phentermine HCl TABLET 8 MG ORAL |
| HIC3 | J8A |
| HIC3 Description | ANTI-OBESITY - ANOREXIC AGENTS |
| GCN | 20715 |
| HICL Sequence Number | 002111 |
| HICL Sequence Number Description | PHENTERMINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | LOMAIRA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Phentermine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENTERMINE HYDROCHLORIDE |
| Labeler Name | KVK-TECH, INC. |
| Pharmaceutical Class | Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA203495 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10702-0001-25 (10702000125)
| NDC Package Code | 10702-001-25 |
|---|---|
| Billing NDC | 10702000125 |
| Package | 250 TABLET in 1 BOTTLE (10702-001-25) |
| Marketing Start Date | 2016-09-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |